持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/05 | 4,925 | 4,925 | 4,815 | 4,850 | -40 | -0.8% | 28,400 |
2019/07/04 | 4,880 | 4,940 | 4,850 | 4,890 | +50 | +1% | 31,800 |
2019/07/03 | 4,830 | 4,910 | 4,830 | 4,840 | -35 | -0.7% | 58,500 |
2019/07/02 | 4,800 | 4,890 | 4,795 | 4,875 | +115 | +2.4% | 47,100 |
2019/07/01 | 4,670 | 4,775 | 4,665 | 4,760 | +175 | +3.8% | 56,700 |
2019/06/28 | 4,680 | 4,700 | 4,565 | 4,585 | -50 | -1.1% | 63,400 |
2019/06/27 | 4,655 | 4,655 | 4,595 | 4,635 | -10 | -0.2% | 42,200 |
2019/06/26 | 4,710 | 4,725 | 4,640 | 4,645 | -60 | -1.3% | 52,000 |
2019/06/25 | 4,735 | 4,800 | 4,705 | 4,705 | -40 | -0.8% | 46,700 |
2019/06/24 | 4,630 | 4,760 | 4,630 | 4,745 | +130 | +2.8% | 51,900 |
2019/06/21 | 4,750 | 4,750 | 4,610 | 4,615 | -150 | -3.1% | 98,000 |
2019/06/20 | 4,775 | 4,835 | 4,765 | 4,765 | ±0 | ±0% | 48,500 |
2019/06/19 | 4,745 | 4,780 | 4,720 | 4,765 | +40 | +0.8% | 84,600 |
2019/06/18 | 4,750 | 4,825 | 4,725 | 4,725 | -15 | -0.3% | 52,900 |
2019/06/17 | 4,785 | 4,820 | 4,735 | 4,740 | -80 | -1.7% | 40,300 |
2019/06/14 | 4,805 | 4,845 | 4,755 | 4,820 | +15 | +0.3% | 50,000 |
2019/06/13 | 4,830 | 4,855 | 4,760 | 4,805 | -65 | -1.3% | 56,000 |
2019/06/12 | 4,845 | 4,915 | 4,815 | 4,870 | -10 | -0.2% | 43,900 |
2019/06/11 | 4,965 | 4,965 | 4,845 | 4,880 | -100 | -2% | 57,500 |
2019/06/10 | 4,960 | 5,000 | 4,935 | 4,980 | +110 | +2.3% | 42,900 |
2019/06/07 | 4,850 | 4,890 | 4,790 | 4,870 | -10 | -0.2% | 55,500 |
2019/06/06 | 4,865 | 4,950 | 4,840 | 4,880 | -5 | -0.1% | 48,200 |
2019/06/05 | 4,885 | 4,890 | 4,790 | 4,885 | +35 | +0.7% | 78,600 |
2019/06/04 | 4,880 | 4,910 | 4,805 | 4,850 | +5 | +0.1% | 52,200 |
2019/06/03 | 4,865 | 4,880 | 4,790 | 4,845 | -115 | -2.3% | 57,400 |
2019/05/31 | 4,990 | 5,020 | 4,950 | 4,960 | -70 | -1.4% | 47,600 |
2019/05/30 | 5,100 | 5,120 | 4,990 | 5,030 | -150 | -2.9% | 47,800 |
2019/05/29 | 5,220 | 5,260 | 5,130 | 5,180 | -150 | -2.8% | 54,700 |
2019/05/28 | 5,370 | 5,380 | 5,300 | 5,330 | -30 | -0.6% | 67,400 |
2019/05/27 | 5,350 | 5,380 | 5,300 | 5,360 | +40 | +0.8% | 34,700 |
2019/05/24 | 5,270 | 5,330 | 5,240 | 5,320 | +70 | +1.3% | 36,200 |
2019/05/23 | 5,200 | 5,280 | 5,150 | 5,250 | +60 | +1.2% | 36,100 |
2019/05/22 | 5,230 | 5,260 | 5,170 | 5,190 | -40 | -0.8% | 31,800 |
2019/05/21 | 5,240 | 5,290 | 5,210 | 5,230 | ±0 | ±0% | 30,200 |
2019/05/20 | 5,280 | 5,310 | 5,220 | 5,230 | -40 | -0.8% | 34,500 |
2019/05/17 | 5,150 | 5,290 | 5,130 | 5,270 | +120 | +2.3% | 53,800 |
2019/05/16 | 4,955 | 5,170 | 4,950 | 5,150 | +225 | +4.6% | 73,500 |
2019/05/15 | 4,865 | 4,935 | 4,800 | 4,925 | -10 | -0.2% | 84,400 |
2019/05/14 | 4,755 | 5,020 | 4,620 | 4,935 | +145 | +3% | 178,900 |
2019/05/13 | 5,000 | 5,010 | 4,765 | 4,790 | -290 | -5.7% | 186,500 |
2019/05/10 | 5,110 | 5,220 | 5,040 | 5,080 | -30 | -0.6% | 94,200 |
2019/05/09 | 5,130 | 5,200 | 5,080 | 5,110 | -90 | -1.7% | 81,000 |
2019/05/08 | 5,100 | 5,220 | 5,050 | 5,200 | +40 | +0.8% | 73,200 |
2019/05/07 | 5,220 | 5,250 | 5,150 | 5,160 | ±0 | ±0% | 109,400 |
2019/04/26 | 5,190 | 5,230 | 5,130 | 5,160 | -20 | -0.4% | 37,900 |
2019/04/25 | 5,140 | 5,210 | 5,140 | 5,180 | -10 | -0.2% | 28,900 |
2019/04/24 | 5,280 | 5,310 | 5,180 | 5,190 | -20 | -0.4% | 35,100 |
2019/04/23 | 5,260 | 5,290 | 5,170 | 5,210 | -40 | -0.8% | 46,800 |
2019/04/22 | 5,170 | 5,270 | 5,090 | 5,250 | +70 | +1.4% | 32,400 |
2019/04/19 | 5,160 | 5,190 | 5,110 | 5,180 | +120 | +2.4% | 54,400 |
1501~
1550
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 311,500円 | +7.9% | -3.3% | 2.57% | 8.66倍 | 0.89倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム